Primary source: Waystar, November 19, 2026 · Waystar investor release, distributed on PR Newswire
On November 19, 2026, Waystar said West Virginia University Health System, which operates as WVU Medicine, selected its AI-powered platform for revenue cycle operations across the enterprise. If you run a health-system revenue cycle, this is a vendor-consolidation decision. The health system keeps the work and changes whose system the claim lives in. Waystar calls the agreement the largest new client win in its history by deal size. The release does not disclose a dollar, a term, or a go-live date.
WVU Medicine will initially consolidate more than a dozen revenue cycle vendors onto Waystar, connecting financial clearance, clinical integrity and revenue capture, claim management, and denial recovery. A subhead says the system "targets millions in potential incremental reimbursement." That phrase is the release's target. It is not a contract value.
The Waystar newsroom item is datelined Lehi, Utah, and Morgantown, W.Va. The same release is on Waystar's investor site, marked as a PR Newswire distribution. The platform name in the release is Waystar AltitudeAI. Waystar describes it as a connected financial operating layer and a system of action, from patient access through final payment.
| Element | What the release establishes |
|---|---|
| The buyer | West Virginia University Health System, operating as WVU Medicine. About section: 31 hospitals in West Virginia, Pennsylvania, Ohio, and Maryland; more than 47,000 employees; $10 billion in total operating revenues. Anchored by an 890-bed academic medical center and the 150-bed WVU Medicine Golisano Children's Hospital in Morgantown. |
| The scope | An initial consolidation of more than a dozen revenue cycle vendors. Functions named: financial clearance, clinical integrity and revenue capture, claim management, and denial recovery. |
| Waystar's ranking | "The largest new client win in Waystar's history by deal size." No dollar value and no term. |
| Waystar's book, not this contract | Approximately 30,000 clients, approximately 1.5 million distinct providers, 16 of 20 institutions on the U.S. News Best Hospitals list, over 8.5 billion healthcare payment transactions a year, over $3.0 trillion in annual gross claims, and approximately 60% of U.S. patients. |
| Not in the release | Contract value, term, go-live date, the names of the vendors being displaced, and the EHR. |
"WVU Medicine is investing in technology that simplifies healthcare administration for our patients and teams while strengthening the financial foundation that supports our mission," said Bahar Bazmi, Chief Revenue Officer for the WVU Health System. "By bringing our revenue cycle operations onto one connected platform, we can reduce complexity, improve financial performance, and give our teams the tools and insights they need to work more effectively. Ultimately, we're building a more sustainable, efficient health system that allows us to invest more in the care we deliver to our communities."
"We're proud to partner with WVU Medicine as it leads the way toward a more autonomous revenue cycle," said Matt Hawkins, Chief Executive Officer of Waystar. "Health systems are recognizing that managing the revenue cycle across dozens of disconnected solutions is no longer sustainable. WVU Medicine is making a significant investment in a simpler, more effective approach. By bringing financial and clinical workflows together on one platform, we can help its teams capture full reimbursement, reduce administrative work, and focus more resources on patient care."
No contract value, no term, no go-live, no vendor list, and no EHR. The forward-looking statement says the timing and success of implementation depend on client resources, client adoption, and the development, deployment, and use of AI. "Millions in potential incremental reimbursement" is a target in that statement, not a fee.
This is RevCycleAI's read. Consolidation onto one technology platform and handing the revenue cycle to a services firm are different operating models, and both showed up in public this week. Children's Mercy selected Ensemble to run acute and physician revenue cycle from scheduling through account resolution. That release left value, term, and a start date blank, and it described the existing team. Waystar's release describes vendors and workflows. It does not describe a staffing transfer. WVU Medicine keeps the revenue cycle. The interfaces change.
"Largest by deal size" is a ranking Waystar is willing to print and a number it is not. For a public company, the sentence tells investors the contract is material relative to other new clients. It does not tell you revenue, duration, or whether the fee is a subscription, a transaction charge, or an outcome share. Waystar's third-quarter results are a different event. This release does not restate those pricing terms, and none are imported here.
The implementation question is the cutover across 31 hospitals and more than a dozen unnamed vendors. Eligibility, clinical integrity, claims, and denial recovery do not have to move on the same day, and the release does not say which day any of them moves. While two systems can both touch a claim, someone still owns the denial. The release does not name that owner. Hawkins's line that disconnected solutions are no longer sustainable is the sales argument for a single platform. It is not evidence that best-of-breed loses on cash, cost to collect, or initial denial rate at this health system. Those rates were not published.
WVU Medicine will initially put more than a dozen revenue cycle vendors on Waystar, and Waystar ranks the agreement as its largest new client win by deal size. The dollar, the term, and the go-live date were not disclosed. The "millions" in the subhead are a target, not a price.
Treat this as a platform consolidation, and ask for the contract shape before you treat the ranking as a result. Still open: the dollar, the term, which vendors leave, which EHR the workflow sits on, and when the first hospital bills on Waystar. Until those are on paper, the operating fact is the vendor count, and the financial fact is that Waystar called the deal its largest new one and declined to price it.
Who runs the revenue cycle, and which number the wire is willing to print.
Sources: Waystar newsroom, published November 19, 2026, datelined Lehi, Utah, and Morgantown, W.Va. (page opened). The same release is on Waystar's investor site (page opened), with a PR Newswire dateline of November 19, 2026. The clock time was not printed on the text retrieved from those two pages, and none is added. Selection of the AI-powered platform, the "largest new client win in Waystar's history by deal size" sentence, the initial consolidation of more than a dozen vendors, the four functions, AltitudeAI, the "connected financial operating layer" and "system of action" language, the subhead on millions in potential incremental reimbursement, Bazmi's and Hawkins's quotations, the client and transaction figures, the 16-of-20 U.S. News line, and the WVU Medicine About figures are the release's. The forward-looking statement is the source for implementation timing depending on client resources, client adoption, and the development, deployment, and use of AI. Contract value, term, go-live date, displaced vendors, and EHR were not disclosed. The November 2 earnings article is a different event and was not used as a source for this contract's terms. The Ensemble–Children's Mercy article is the same-day comparison. The RevCycleAI analysis is our read.